TY - JOUR T1 - Novel Spatiotemporal Feature Extraction Parallel Deep Neural Network for Forecasting Confirmed Cases of Coronavirus Disease 2019 JF - medRxiv DO - 10.1101/2020.04.30.20086538 SP - 2020.04.30.20086538 AU - Chiou-Jye Huang AU - Yamin Shen AU - Ping-Huan Kuo AU - Yung-Hsiang Chen Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/05/2020.04.30.20086538.abstract N2 - The coronavirus disease 2019 pandemic continues as of March 26 and spread to Europe on approximately February 24. A report from April 29 revealed 1.26 million confirmed cases and 125 928 deaths in Europe. This study proposed a novel deep neural network framework, COVID-19Net, which parallelly combines a convolutional neural network (CNN) and bidirectional gated recurrent units (GRUs). Three European countries with severe outbreaks were studied—Germany, Italy, and Spain—to extract spatiotemporal feature and predict the number of confirmed cases. The prediction results acquired from COVID-19Net were compared to those obtained using a CNN, GRU, and CNN-GRU. The mean absolute error, mean absolute percentage error, and root mean square error, which are commonly used model assessment indices, were used to compare the accuracy of the models. The results verified that COVID-19Net was notably more accurate than the other models. The mean absolute percentage error generated by COVID-19Net was 1.447 for Germany, 1.801 for Italy, and 2.828 for Spain, which were considerably lower than those of the other models. This indicated that the proposed framework can accurately predict the accumulated number of confirmed cases in the three countries and serve as a crucial reference for devising public health strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Ministry of Science and Technology, Taiwan, under Grants MOST 106-2218-E-153-001-MY3.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData were acquired from the daily situation reports disclosed by the WHO ER -